Vitura Health Limited (ASX:VIT)
0.0410
-0.0050 (-10.87%)
At close: Mar 4, 2026
Vitura Health Revenue
Vitura Health had revenue of 61.36M AUD in the half year ending June 30, 2025, with 2.81% growth. This brings the company's revenue in the last twelve months to 129.24M, up 2.11% year-over-year. In the fiscal year ending June 30, 2025, Vitura Health had annual revenue of 124.04M with 0.13% growth.
Revenue (ttm)
129.24M
Revenue Growth
+2.11%
P/S Ratio
0.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 124.04M | 166.10K | 0.13% |
| Jun 30, 2024 | 123.87M | 6.53M | 5.56% |
| Jun 30, 2023 | 117.34M | 50.35M | 75.16% |
| Jun 30, 2022 | 66.99M | 45.28M | 208.54% |
| Jun 30, 2021 | 21.71M | 21.59M | 17,431.02% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vita Life Sciences | 93.27M |
| Medical Developments International | 40.64M |
| Little Green Pharma | 38.49M |
| ECS Botanics Holdings | 19.36M |
| IDT Australia | 19.00M |
| Peak Processing | 14.59M |
| Cann Group | 11.44M |
| Epsilon Healthcare | 9.39M |